Nanopublications LDF server

Matches in Nanopublications for { ?s ?p "[These findings confirm that germline GATA2 mutations predispose to familial myelodysplastic syndrome/acute myeloid leukemia, and that monosomy 7 and ASXL1 mutations may be recurrent secondary genetic abnormalities triggering overt malignancy in these families.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }

• NP209461.RAA_kmpZJGjiyBS20nlVk5gu45rPi-1Mfa1MRdAfJsZ90130_assertion description "[These findings confirm that germline GATA2 mutations predispose to familial myelodysplastic syndrome/acute myeloid leukemia, and that monosomy 7 and ASXL1 mutations may be recurrent secondary genetic abnormalities triggering overt malignancy in these families.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP209461.RAA_kmpZJGjiyBS20nlVk5gu45rPi-1Mfa1MRdAfJsZ90130_provenance.
• NP222907.RAeRV5T6we0S3MqCAbnIT-EHmsU49PpPhpfh8F4SWTEYg130_assertion description "[These findings confirm that germline GATA2 mutations predispose to familial myelodysplastic syndrome/acute myeloid leukemia, and that monosomy 7 and ASXL1 mutations may be recurrent secondary genetic abnormalities triggering overt malignancy in these families.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP222907.RAeRV5T6we0S3MqCAbnIT-EHmsU49PpPhpfh8F4SWTEYg130_provenance.
• NP635818.RAaPD1w3iSmj-9QNgkkTMPr1JEIM6cCFCAj08SbWoW4SM130_assertion description "[These findings confirm that germline GATA2 mutations predispose to familial myelodysplastic syndrome/acute myeloid leukemia, and that monosomy 7 and ASXL1 mutations may be recurrent secondary genetic abnormalities triggering overt malignancy in these families.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP635818.RAaPD1w3iSmj-9QNgkkTMPr1JEIM6cCFCAj08SbWoW4SM130_provenance.
• NP190888.RAdARz7RNG-mEM2GuqGBsQB-JutDYRH0pxlbPf7mdoAHM130_assertion description "[These findings confirm that germline GATA2 mutations predispose to familial myelodysplastic syndrome/acute myeloid leukemia, and that monosomy 7 and ASXL1 mutations may be recurrent secondary genetic abnormalities triggering overt malignancy in these families.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP190888.RAdARz7RNG-mEM2GuqGBsQB-JutDYRH0pxlbPf7mdoAHM130_provenance.
• NP301537.RApXGxue2QrHIumfBILPtiA2MLX8SXwJtEPQH86LzX4po130_assertion description "[These findings confirm that germline GATA2 mutations predispose to familial myelodysplastic syndrome/acute myeloid leukemia, and that monosomy 7 and ASXL1 mutations may be recurrent secondary genetic abnormalities triggering overt malignancy in these families.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP301537.RApXGxue2QrHIumfBILPtiA2MLX8SXwJtEPQH86LzX4po130_provenance.
• NP336210.RA_0jMDZ9gyQgSZKiBFkN44WyEspcjPEmMdPGvAaZVItU130_assertion description "[These findings confirm that germline GATA2 mutations predispose to familial myelodysplastic syndrome/acute myeloid leukemia, and that monosomy 7 and ASXL1 mutations may be recurrent secondary genetic abnormalities triggering overt malignancy in these families.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP336210.RA_0jMDZ9gyQgSZKiBFkN44WyEspcjPEmMdPGvAaZVItU130_provenance.
• NP418949.RASLc0OD0iSe-Oz4AmUpgznVUUpESgbb5yT0MtWYCfTxA130_assertion description "[These findings confirm that germline GATA2 mutations predispose to familial myelodysplastic syndrome/acute myeloid leukemia, and that monosomy 7 and ASXL1 mutations may be recurrent secondary genetic abnormalities triggering overt malignancy in these families.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP418949.RASLc0OD0iSe-Oz4AmUpgznVUUpESgbb5yT0MtWYCfTxA130_provenance.
• NP419050.RAQIckuPaHl4F1waKs-SkPB6HfzQ52wGrCMNXPbLkl6t8130_assertion description "[These findings confirm that germline GATA2 mutations predispose to familial myelodysplastic syndrome/acute myeloid leukemia, and that monosomy 7 and ASXL1 mutations may be recurrent secondary genetic abnormalities triggering overt malignancy in these families.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP419050.RAQIckuPaHl4F1waKs-SkPB6HfzQ52wGrCMNXPbLkl6t8130_provenance.
• NP978423.RAWgqVw5NgEaGtwZGuO68E4fqxLa4R9_ULcTTpQxSvjjw130_assertion description "[These findings confirm that germline GATA2 mutations predispose to familial myelodysplastic syndrome/acute myeloid leukemia, and that monosomy 7 and ASXL1 mutations may be recurrent secondary genetic abnormalities triggering overt malignancy in these families.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP978423.RAWgqVw5NgEaGtwZGuO68E4fqxLa4R9_ULcTTpQxSvjjw130_provenance.
• NP602049.RAG9GF2z2Cs6unzX3qocrL2_PzpE5ShRy62ACKXZ1Ad9Y130_assertion description "[These findings confirm that germline GATA2 mutations predispose to familial myelodysplastic syndrome/acute myeloid leukemia, and that monosomy 7 and ASXL1 mutations may be recurrent secondary genetic abnormalities triggering overt malignancy in these families.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP602049.RAG9GF2z2Cs6unzX3qocrL2_PzpE5ShRy62ACKXZ1Ad9Y130_provenance.
• NP955591.RAjybvMgYPVzoY-B82b2jDWE4VdouEDOOGZjf6gxzZSkE130_assertion description "[These findings confirm that germline GATA2 mutations predispose to familial myelodysplastic syndrome/acute myeloid leukemia, and that monosomy 7 and ASXL1 mutations may be recurrent secondary genetic abnormalities triggering overt malignancy in these families.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP955591.RAjybvMgYPVzoY-B82b2jDWE4VdouEDOOGZjf6gxzZSkE130_provenance.
• NP418924.RAKQnlsrf3ybNCLXHGtw1RjrXNoSAWIfLj5FU5q1GsL-Y130_assertion description "[These findings confirm that germline GATA2 mutations predispose to familial myelodysplastic syndrome/acute myeloid leukemia, and that monosomy 7 and ASXL1 mutations may be recurrent secondary genetic abnormalities triggering overt malignancy in these families.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP418924.RAKQnlsrf3ybNCLXHGtw1RjrXNoSAWIfLj5FU5q1GsL-Y130_provenance.
• NP978693.RANJODhvmzfP1zM7sgqlNghT-vLHL6hhJf56Sy_8L9Jp4130_assertion description "[These findings confirm that germline GATA2 mutations predispose to familial myelodysplastic syndrome/acute myeloid leukemia, and that monosomy 7 and ASXL1 mutations may be recurrent secondary genetic abnormalities triggering overt malignancy in these families.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP978693.RANJODhvmzfP1zM7sgqlNghT-vLHL6hhJf56Sy_8L9Jp4130_provenance.